Dimethylstilbestrol: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Dimethylstilbestrol}} | |||
== | == Dimethylstilbestrol == | ||
[[File:Dimethylstilbestrol.svg|thumb|right|Chemical structure of Dimethylstilbestrol]] | |||
'''Dimethylstilbestrol''' (DMS) is a synthetic nonsteroidal [[estrogen]] of the [[stilbestrol]] group. It is chemically related to [[diethylstilbestrol]] (DES), which is more widely known and studied. DMS was developed in the early 20th century and has been used in various medical applications, although its use has declined due to safety concerns. | |||
== | == Chemical Properties == | ||
Dimethylstilbestrol is a [[stilbene]] derivative, characterized by its two phenyl rings connected by a carbon-carbon double bond. The chemical formula of DMS is C<sub>18</sub>H<sub>20</sub>O<sub>2</sub>. It is a crystalline solid at room temperature and is soluble in organic solvents. | |||
==Mechanism of Action== | == Mechanism of Action == | ||
As an estrogen, DMS binds to and activates the [[estrogen receptor]]s in the body. This activation leads to the transcription of estrogen-responsive genes, which can influence a variety of physiological processes, including the regulation of the [[menstrual cycle]], maintenance of [[bone density]], and modulation of [[lipid metabolism]]. | |||
== | == Medical Uses == | ||
Historically, dimethylstilbestrol was used in the treatment of [[menopausal symptoms]], [[prostate cancer]], and as a component of [[hormone replacement therapy]]. However, its use has been largely discontinued due to the discovery of significant adverse effects associated with similar compounds like diethylstilbestrol. | |||
== | == Adverse Effects == | ||
The | The use of synthetic estrogens like DMS has been associated with an increased risk of [[thromboembolic events]], [[breast cancer]], and [[endometrial cancer]]. These risks have led to a reevaluation of the safety of such compounds, and they are now rarely used in clinical practice. | ||
== | == Historical Context == | ||
Dimethylstilbestrol was developed during a period when synthetic estrogens were being explored for a variety of medical applications. The adverse effects observed with diethylstilbestrol, particularly its teratogenic effects when used during pregnancy, have overshadowed the use of DMS and similar compounds. | |||
== Related Compounds == | |||
* [[Diethylstilbestrol]] (DES) | |||
* [[Stilbestrol]] | |||
* [[Estradiol]] | |||
== Related Pages == | |||
* [[Estrogen]] | * [[Estrogen]] | ||
* [[Hormone replacement therapy]] | * [[Hormone replacement therapy]] | ||
* [[ | * [[Prostate cancer]] | ||
[[Category: | [[Category:Estrogens]] | ||
[[Category: | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Pharmacology]] | ||
Latest revision as of 05:26, 16 February 2025
Dimethylstilbestrol[edit]
Dimethylstilbestrol (DMS) is a synthetic nonsteroidal estrogen of the stilbestrol group. It is chemically related to diethylstilbestrol (DES), which is more widely known and studied. DMS was developed in the early 20th century and has been used in various medical applications, although its use has declined due to safety concerns.
Chemical Properties[edit]
Dimethylstilbestrol is a stilbene derivative, characterized by its two phenyl rings connected by a carbon-carbon double bond. The chemical formula of DMS is C18H20O2. It is a crystalline solid at room temperature and is soluble in organic solvents.
Mechanism of Action[edit]
As an estrogen, DMS binds to and activates the estrogen receptors in the body. This activation leads to the transcription of estrogen-responsive genes, which can influence a variety of physiological processes, including the regulation of the menstrual cycle, maintenance of bone density, and modulation of lipid metabolism.
Medical Uses[edit]
Historically, dimethylstilbestrol was used in the treatment of menopausal symptoms, prostate cancer, and as a component of hormone replacement therapy. However, its use has been largely discontinued due to the discovery of significant adverse effects associated with similar compounds like diethylstilbestrol.
Adverse Effects[edit]
The use of synthetic estrogens like DMS has been associated with an increased risk of thromboembolic events, breast cancer, and endometrial cancer. These risks have led to a reevaluation of the safety of such compounds, and they are now rarely used in clinical practice.
Historical Context[edit]
Dimethylstilbestrol was developed during a period when synthetic estrogens were being explored for a variety of medical applications. The adverse effects observed with diethylstilbestrol, particularly its teratogenic effects when used during pregnancy, have overshadowed the use of DMS and similar compounds.
